Literature DB >> 11043773

Rel/NF-kappaB transcription factors: key mediators of B-cell activation.

R Gugasyan1, R Grumont, M Grossmann, Y Nakamura, T Pohl, D Nesic, S Gerondakis.   

Abstract

The Rel/nuclear factor (NF)-kappaB family of transcription factors have been implicated in the regulation of a wide variety of genes, in particular those encoding proteins crucial to the function of the immune system. Through the use of mutant mice that lack one or more of these proteins, we have begun to examine the individual and combined roles of Rel, RelA and NF-kappaB1 in B-cell development and function. Here we outline and discuss how these transcription factors operate as differentiation stage-specific regulators of B-cell development, survival, division and immunoglobulin expression, emphasizing those Rel/NF-kappaB-regulated genes that mediate these functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043773     DOI: 10.1034/j.1600-065x.2000.00615.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  33 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Distribution of NF-kappaB-binding sites across human chromosome 22.

Authors:  Rebecca Martone; Ghia Euskirchen; Paul Bertone; Stephen Hartman; Thomas E Royce; Nicholas M Luscombe; John L Rinn; F Kenneth Nelson; Perry Miller; Mark Gerstein; Sherman Weissman; Michael Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

3.  Infection with chicken anaemia virus impairs the generation of pathogen-specific cytotoxic T lymphocytes.

Authors:  Carrie J Markowski-Grimsrud; Karel A Schat
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

4.  Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.

Authors:  Song He; Xiaobing Miao; Yaxun Wu; Xinghua Zhu; Xianjing Miao; Haibing Yin; Yunhua He; Chunsun Li; Yushan Liu; Xiaoyun Lu; Yali Chen; Yuchan Wang; Xiaohong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-23       Impact factor: 4.553

5.  Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

Authors:  Manfred Fliegauf; Vanessa L Bryant; Natalie Frede; Charlotte Slade; See-Tarn Woon; Klaus Lehnert; Sandra Winzer; Alla Bulashevska; Thomas Scerri; Euphemia Leung; Anthony Jordan; Baerbel Keller; Esther de Vries; Hongzhi Cao; Fang Yang; Alejandro A Schäffer; Klaus Warnatz; Peter Browett; Jo Douglass; Rohan V Ameratunga; Jos W M van der Meer; Bodo Grimbacher
Journal:  Am J Hum Genet       Date:  2015-08-13       Impact factor: 11.025

6.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy.

Authors:  Tina Jaskoll; George Abichaker; Nolan Jangaard; Pablo Bringas; Michael Melnick
Journal:  Arch Oral Biol       Date:  2008-01-16       Impact factor: 2.633

8.  NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.

Authors:  Yukio Nakamura; Raelene J Grumont; Steve Gerondakis
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Role of zeta PKC in B-cell signaling and function.

Authors:  Pilar Martin; Angeles Duran; Susana Minguet; María-Luisa Gaspar; Maria-Teresa Diaz-Meco; Paul Rennert; Michael Leitges; Jorge Moscat
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  NF-kappaB activity marks cells engaged in receptor editing.

Authors:  Emily J Cadera; Fengyi Wan; Rupesh H Amin; Hector Nolla; Michael J Lenardo; Mark S Schlissel
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.